cetuximab FDA approval date

The FDA approved cetuximab on 12 Feb 2004.

FDA approval date
12 Feb 2004

Drug identity checked against registry records

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal CancerNCT07659795VSTMPhase 2Recruiting2027-06Estimated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerNCT07644559VSTMPhase 2Recruiting2027-06Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2004-02-12DaycetuximabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125084", "applicant_as_listed_by_fda": "IMCLONE", "brand_names": ["ERBITUX"], "active_ingredients": ["CETUXIMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20040212", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026